C-Mer Eye Care Holdings (HKSE:03309) Cash And Cash Equivalents : HK$513 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is C-Mer Eye Care Holdings Cash And Cash Equivalents?

C-Mer Eye Care Holdings's quarterly cash and cash equivalents declined from Dec. 2022 (HK$644.70 Mil) to Jun. 2023 (HK$563.12 Mil) but then stayed the same from Jun. 2023 (HK$563.12 Mil) to Dec. 2023 (HK$512.76 Mil).

C-Mer Eye Care Holdings's annual cash and cash equivalents increased from Dec. 2021 (HK$386.66 Mil) to Dec. 2022 (HK$644.70 Mil) but then declined from Dec. 2022 (HK$644.70 Mil) to Dec. 2023 (HK$512.76 Mil).

C-Mer Eye Care Holdings Cash And Cash Equivalents Historical Data

The historical data trend for C-Mer Eye Care Holdings's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C-Mer Eye Care Holdings Cash And Cash Equivalents Chart

C-Mer Eye Care Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

282.18

553.93

386.66

644.70

512.76

C-Mer Eye Care Holdings Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial													386.66	631.70	644.70	563.12	512.76

C-Mer Eye Care Holdings Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

C-Mer Eye Care Holdings (HKSE:03309) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

C-Mer Eye Care Holdings Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of C-Mer Eye Care Holdings's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

C-Mer Eye Care Holdings (HKSE:03309) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » C-Mer Eye Care Holdings Ltd (HKSE:03309) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-3 Pedder Street, Suite 1335, Central Building, Central, Hong Kong, HKG

Website

https://www.cmereye.com

C-Mer Eye Care Holdings Ltd provides general medical and surgical hospital services. It provides ophthalmic health care, diagnosis, treatment, surgical treatment services, and the sale of vision aid and pharmaceutical products in Hong Kong and the People's Republic of China. The company offers cataract, cornea, and ocular surface diseases, glaucoma, vitreoretinal and macular diseases, other eye diseases diagnosis and treatment services, and Chinese medicine treatment of eye diseases. Its segments include Sales of medical consumables, Mainland China ophthalmic business and Mainland China dental business. It generates a vast majority of its revenue from the provision of the ophthalmic services segment.

Executives

C-mer Group Limited	2101 Beneficial owner
Lam Shun Chiu Dennis	2201 Interest of corporation controlled by you
Li Xiaoting	2201 Interest of corporation controlled by you

C-Mer Eye Care Holdings (HKSE:03309) Headlines

No Headlines